Provider review
Fridays review
Its named microdose costs more than double its own semaglutide headline.
Two pages one click apart price the smaller dose above the larger one, for the same molecule, from the same seller.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Fridays
$198/mo microdose tirzepatide, $249/mo microdose semaglutide
- Vs median
- $29/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Prices the low dose on its own
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
This is the clearest example we have found of the thing this site was built to look for. Fridays sells a genuine, named microdose product — its own navigation has a Microdosing tab, the page describes weekly injections or daily oral tablets, and both products carry plain unconditional monthly prices with no code and no term attached. It also sells the ordinary full-dose versions of the same two molecules. Put the two pages side by side and the microdose semaglutide costs more than twice what the standard semaglutide headline says, while the microdose tirzepatide costs exactly what the standard tirzepatide headline says. Taking less does not cost less here. For semaglutide it costs considerably more. The headlines need their own warning, because they are the numbers a reader carries away. Neither is a rate anyone pays by default: each card also prints an annual-plan price roughly twice as high next to a discount code, and the arithmetic settles which is which, since 58% off the plan price lands exactly on the advertised figure. No month-to-month rate is published for either compounded product at all. The microdose prices are the unconditional ones, which is why this row is ranked on them, and it is worth sitting with what that means — the only prices here you can rely on are the ones charging you more to take less.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a named microdose product with its own page and its own stated price
- You want dietitian and coaching support bundled rather than sold separately
- You want brand-name Ozempic or Zepbound available month-to-month alongside the compounded route
Look elsewhere if
- You are microdosing to spend less. Here the microdose semaglutide costs more than double the standard headline
- You want to pay monthly for a compounded plan. No month-to-month rate is published
- You dislike coupon pricing; both headline figures need a code and an annual plan
What it actually costs
Price as published
THE MICRODOSE COSTS MORE THAN THE FULL DOSE, from the same seller, on two pages one click apart. /microdosing prices compounded microdose semaglutide at $249/month and compounded microdose tirzepatide at $198/month, both flat, with no term and no code attached · /pricing headlines the standard products at "Semaglutide: $117/mo (Lowest Price)" and "Tirzepatide: As low as $198/mo" · so microdose semaglutide is more than twice the standard semaglutide headline, and microdose tirzepatide is exactly the standard tirzepatide headline · AND THE HEADLINES ARE COUPON RATES: each card prints "$279/mo with an annual plan" beside the $117 with "SAVE 58% use code NYNY12", and "$389/mo with an annual plan" beside the $198 with "SAVE 50% use code NEWYOU12" — 58% off $279 is $117, so the advertised figure is a discount code applied to an annual plan · no month-to-month rate is published for either compounded product · brand-name Ozempic $1,498/mo and Zepbound $1,828/mo are month-to-month; the Wegovy pill and pen show only a $49 first-month membership with "meds excl."
- Vs median
- $29/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Prices the low dose on its own
Publishes a price for a microdose track, but no standard-dose price alongside it — so you can cost the low dose, you just cannot see what it saves you.
17 of the 373 programs we track price a small dose this way. ★★★ THE CLEAREST CASE OF THE THING THIS PAGE EXISTS TO FIND. There is a real named microdose product for both molecules, on its own page, with its own unconditional monthly price — and for semaglutide that price is more than DOUBLE the seller's own headline for the ordinary full-dose version of the same drug. The microdose tirzepatide lands exactly on the standard tirzepatide headline. Both of those headlines are discount-code rates on an annual plan, with the plan price printed beside them at roughly twice as much, so the standard products are being shown at their most flattering and the microdose still costs the same or more. Taking less does not cost less here.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Sells a genuine named microdose product for both molecules, with its own page and its own price.
- The microdose prices are unconditional — no code, no term, no annual plan attached.
- Brand-name Ozempic and Zepbound are offered month-to-month alongside the compounded route.
Pharmacy, labs and oversight
Fridays does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Fridays publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Fridays is the clearest case on this page of the thing this site was built to find. It sells a real, named microdose product — its own nav has a Microdosing tab, the page describes weekly injections or daily oral tablets, and the two products carry plain unconditional monthly prices. It also sells the standard full-dose versions of the same two molecules. Set the two pages beside each other and the microdose semaglutide costs $249 a month against a $117 headline for the ordinary one, and the microdose tirzepatide costs exactly what the ordinary tirzepatide costs. Taking less does not cost less here; for semaglutide it costs more than twice as much. The headline figures deserve their own warning, because they are the numbers a reader will carry away. Neither is a rate anybody pays by default: each sits on a card that also prints an annual-plan price roughly twice as high and a discount code, and the arithmetic confirms which is which — 58% off $279 is $117 to the dollar. What is not published anywhere is a month-to-month rate for either compounded product. The microdose prices, by contrast, are unconditional, which is the reason this row is ranked on them.
The honest cons
The microdose semaglutide costs more than twice the seller's own semaglutide headline.
- Both headline figures are discount-code rates on an annual plan; the plan price is roughly double.
- No month-to-month rate is published for either compounded product.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Fridays is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#293 of 373
Ordered with the companies that pay us first, and Fridays is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Aurelius Health Group
$89 first month, then $199/mo
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Prices the low dose on its own
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Aurelius Health Group review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.